anti-CD3/anti-CD133 bispecific T-cell engager (McMaster University/University of Toronto)

N/A

Report date: 2026/03/19 16:57:16

Base Information

Drug Nameanti-CD3/anti-CD133 bispecific T-cell engager (McMaster University/University of Toronto)
Drug Alias NameCD133/CD3 bispecific T-cell engager antibody (McMaster University/University of Toronto)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsCD133 modulators
TargetsCD133T cell surface glycoprotein CD3
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMcmaster University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of TorontoMcmaster University
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A